Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) Subjects

Recruiting now

Conditions studied: Choroidal Melanoma, Indeterminate Lesions, Uveal Melanoma, Ocular Melanoma

In brief

To assess subject-centric real-world evidence of QoL outcomes in subjects enrolled in the global Phase 3 AU-011-301 clinical trial.

Key facts

Study ID

NCT07421739

Run by

Aura Biosciences

People needed

15

Starts

2025-11-12

Expected to finish

2028-08-15

Last updated by the study team

2026-02-19

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Have enrolled in the Aura-sponsored clinical trial AU-011-301.
• Access to a connected device (i.e., smartphone, laptop, or tablet)

You may not qualify if…

• None

Where it is running

• Eye Research Australia — East Melbourne, Victoria, Australia (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.